Characterization of serum biomarkers in individuals with SCI receiving Acute Intermittent Hypoxia

Body

We seek to quantify the serum inflammatory markers in individuals with SCI, and correlate inflammation with responsiveness to AIH therapy.

Participants in this study will:

• Attend 2 sessions at Shirley Ryan AbilityLab, about 1 week apart, each lasting about 4 hours
• Be fitted with a face-mask, and be provided with brief episodes of lower levels of oxygen alternating with normal room air.
• Be asked to complete 2 blood draws and 2 sessions of ankle strength measurements ( with ultrasound.)